Insider Stock Trading History of Claiborne Cary J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Claiborne Cary J since year 2005. The trader's CIK number is 1370930. At the time of this reporting, Claiborne Cary J is the of Sucampo Pharmaceuticals, Inc. . (stock ticker symbol SCMP). See this page for all insider trading activities at Sucampo Pharmaceuticals, Inc. .

Note that in the past Claiborne Cary J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Claiborne Cary J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-12-15 SCMP Sucampo Pharmaceuticals, Inc. Option Ex 7,100 4.07 28,897
2014-12-16 SCMP Sucampo Pharmaceuticals, Inc. Option Ex 42,900 4.07 174,603
2014-12-15 SCMP Sucampo Pharmaceuticals, Inc. Sale 7,100 12.89 91,519
2014-12-16 SCMP Sucampo Pharmaceuticals, Inc. Sale 42,900 12.91 553,839
2014-02-27 SCMP Sucampo Pharmaceuticals, Inc. Option Ex 2,500 4.07 10,175
2014-02-27 SCMP Sucampo Pharmaceuticals, Inc. Sale 2,500 9.03 22,575
2014-01-07 SCMP Sucampo Pharmaceuticals, Inc. Option Ex 2,500 4.24 10,600
2014-01-07 SCMP Sucampo Pharmaceuticals, Inc. Sale 2,500 9.00 22,500
2013-05-20 SCMP Sucampo Pharmaceuticals, Inc. Sale 2,240 9.50 21,280
2013-05-21 SCMP Sucampo Pharmaceuticals, Inc. Sale 2,400 9.55 22,912
2009-12-24 NGBF Wireless Holdings Inc Buy 10,000 .68 6,840
2009-12-28 NGBF Wireless Holdings Inc Buy 10,000 .74 7,370
2009-12-18 NGBF Wireless Holdings Inc Buy 10,000 .71 7,100
2009-12-21 NGBF Wireless Holdings Inc Buy 10,000 .70 6,949
2007-03-02 OSIR Osiris Therapeutics, Inc. Option Ex 15,000 .40 6,000
2006-09-27 OSIR Osiris Therapeutics, Inc. Option Ex 45,000 .40 18,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Claiborne Cary J ( of Sucampo Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.